OneMedNet (ONMD) Stock Price, News & Analysis

Company Overview

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository. OneMedNet focuses on real-world data, including medical images and associated clinical information, to support areas such as clinical research, artificial intelligence development, drug discovery and healthcare analytics.

OneMedNet became a publicly traded company following the completion of a business combination with Data Knights Acquisition Corp. Its operations are aimed at serving healthcare and life sciences organizations that require secure, privacy-conscious access to distributed datasets. The company’s offerings and geographic reach may evolve as it expands its network of participating institutions and commercial partners.

Key Stats

• Today's Range: $4.12 to $4.71
• 50-Day Range: $3.93 to $7.81
• 52-Week Range: $3.61 to $31.00
• Volume: 104,565 shs
• Average Volume: 71,535 shs
• Market Capitalization: $27.93 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

OneMedNet Stock Analysis - MarketRank™

OneMedNet scored higher than 28% of companies evaluated by MarketBeat, and ranked 668th out of 873 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

OneMedNet has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

OneMedNet has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of OneMedNet is -2.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of OneMedNet is -2.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.85% of the float of OneMedNet has been sold short.

Short Interest Ratio / Days to Cover

OneMedNet has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in OneMedNet has recently decreased by 87.69%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

OneMedNet does not currently pay a dividend.

Dividend Growth

OneMedNet does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.44

News Sentiment

OneMedNet has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 20 news articles for OneMedNet this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for ONMD on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

Company Ownership

• Score: 4.3 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

2 insiders have purchased shares of OneMedNet in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $1,986,949.00 in company stock, which represents 7.1140% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, OneMedNet insiders have bought 1,928.29% more of their company's stock than they have sold. Specifically, they have bought $2,089,991.00 in company stock and sold $103,042.00 in company stock.

Percentage Held by Insiders

50.20% of the stock of OneMedNet is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

0.95% of the stock of OneMedNet is held by institutions.

Company Calendar

• Last Earnings: 11/14/2025
• Today: 10/14/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NASDAQ:ONMD
• Previous Symbol: NASDAQ:DKDCA
• CIK: 1849380
• Web: www.onemednet.com
• Phone: +011442080902009
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($1.60)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.80 million
• Net Margins: -584.20%
• Pretax Margin: -584.14%
• Return on Equity: N/A
• Return on Assets: -521.20%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.28
• Quick Ratio: 0.28

Sales & Book Value

• Annual Sales: $1.36 million
• Price / Sales: 20.54
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.58) per share
• Price / Book: -8.12

Miscellaneous

• Outstanding Shares: 5,930,000
• Free Float: 2,953,000
• Market Cap: $27.93 million
• Optionable: N/A
• Beta: 1.14